| Sandoz Pharmaceuticals AG - Irinotecan Sandoz 150 mg/7.5 ml, Infusionskonzentrat |
| 59438 | | 03 | | Irinotecan Sandoz 150 mg/7.5 ml | | Infusionskonzentrat | | L01XX19 | | Irinotecan | | 04.12.2009 | | |
|
| Composition |
| irinotecani hydrochloridum trihydricum 150 mg, sorbitolum, acidum lacticum, aqua ad iniectabilia q.s. ad solutionem pro 7.5 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Irinotecan Hydrochloride Trihydrate | 150mg / 7.5ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 014 | Durchstechflasche(n) | 158.91 | 198.85 | A | | Yes |
|
